130 related articles for article (PubMed ID: 8838980)
1. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Malathi I; Ng KC
Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
[TBL] [Abstract][Full Text] [Related]
2. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
[TBL] [Abstract][Full Text] [Related]
6. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
[TBL] [Abstract][Full Text] [Related]
9. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
[TBL] [Abstract][Full Text] [Related]
11. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Corbet A; Bucciarelli R; Goldman S; Mammel M; Wold D; Long W
J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961
[TBL] [Abstract][Full Text] [Related]
12. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A
Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
14. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
Pfenninger J; Aebi C; Bachmann D; Wagner BP
Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
[TBL] [Abstract][Full Text] [Related]
15. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
Lloyd J; Todd DA; John E
Early Hum Dev; 1999 Mar; 54(2):157-68. PubMed ID: 10213294
[TBL] [Abstract][Full Text] [Related]
16. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
17. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
18. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
19. Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.
Easa D; Pelke S; Nakamura KT; Barrett J; Balaraman V; Loo SW; Ibarra-Pratt E; Smith MB
Pediatr Pulmonol; 1992 Sep; 14(1):16-22. PubMed ID: 1437338
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical responses to natural and synthetic surfactants.
Rollins M; Jenkins J; Tubman R; Corkey C; Wilson D
J Perinat Med; 1993; 21(5):341-7. PubMed ID: 8126629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
